Gulf International Bank (Uk) LTD Gilead Sciences, Inc. Transaction History
Gulf International Bank (Uk) LTD
- $3.9 Billion
- Q3 2024
A detailed history of Gulf International Bank (Uk) LTD transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Gulf International Bank (Uk) LTD holds 98,705 shares of GILD stock, worth $8.87 Million. This represents 0.21% of its overall portfolio holdings.
Number of Shares
98,705
Previous 103,127
4.29%
Holding current value
$8.87 Million
Previous $7.08 Million
16.96%
% of portfolio
0.21%
Previous 0.18%
Shares
26 transactions
Others Institutions Holding GILD
# of Institutions
1,931Shares Held
991MCall Options Held
10.5MPut Options Held
9.75M-
Black Rock Inc. New York, NY121MShares$10.8 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA115MShares$10.4 Billion0.18% of portfolio
-
Capital World Investors Los Angeles, CA76.5MShares$6.88 Billion1.03% of portfolio
-
Capital Research Global Investors Los Angeles, CA61.8MShares$5.55 Billion1.12% of portfolio
-
State Street Corp Boston, MA60.2MShares$5.41 Billion0.21% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $113B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...